Empty Package, Levittown, PA, USA
1 week ago •reported by user-ydpht521
1 year ago •source www.fda.gov
Recall notice
United States
Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary recall was initiated due to dissolution test failure detected during routine stability testing. No other lots are impacted.1 week ago •reported by user-ydpht521
2 weeks ago •reported by user-djzyb457
3 weeks ago •reported by user-kqzmv138
2 weeks ago •reported by user-rrfzf831
4 weeks ago •reported by user-cmkp9446
1 day ago •reported by user-kwwr7591
6 days ago •reported by user-jwwtf638
1 week ago •reported by user-rfch4519
4 weeks ago •reported by user-kjny1173
2 weeks ago •reported by user-pwhgw935
IMPORTANT - YOUR REPORT IS QUEUED - IT MAY TAKE UP TO 12 HOURS FOR YOUR REPORT TO SHOW ON OUR HOME PAGE (IF NOT OPTED AS PRIVATE)
Visit our learn pages for more helpful information or, email us: support@safelyhq.com
Search